THERAPEUTICALLY "REFRACTORY" HYPERTENSION: CAUSATIVE FACTORS, AND MEDICAL MANAGEMENT WITH CHLOROTHIAZIDE AND OTHER AGENTS
- 1 November 1958
- journal article
- research article
- Published by American College of Physicians in Annals of Internal Medicine
- Vol. 49 (5) , 1129-1137
- https://doi.org/10.7326/0003-4819-49-5-1129
Abstract
Thirty-five cases of refractory hypertensive disease were treated with chlorothiazide 1.0 gm/day, added to drugs that previously were ineffective in lowering their blood pressure. All but 3 cases showed a prompt and impressive hypotensive response. The mechanism of action was not thought to be due exclusively to electrolyte loss. Side reactions to chlorothiazide were minor, generally, and of 4 types; gastrointestinal, hemorrhagic, cardiac, and possibly central nervous. Cardiac arrythmias were occasionally distressing, but were not related to electrolyte changes in the plasma. Therapy of hypertensive disease should begin with milder drugs, such as reserpine and hydralazine; if no response is found, chlorothiazide should be added to them, with appropriate chemical follow up and control. Failure to obtain a blood pressure reduction at this point is reason for supplementing these drugs with the autonomic blocking compounds, in appropriate patients.Keywords
This publication has 2 references indexed in Scilit:
- RESERPINE-HYDRALAZINE COMBINATION THERAPY OF HYPERTENSIVE DISEASE, WITH HYDRALAZINE IN DOSES GENERALLY BELOW THE "TOXIC RANGE"Annals of Internal Medicine, 1956
- NEW DRUG THERAPIES IN ARTERIAL HYPERTENSIONAnnals of Internal Medicine, 1952